Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-20-012325

VP, Clinical&Translational Sc sold 371 shares at $17.81 ($6,608)

  • VP, Clinical&Translational Sc acquired 1,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-12-27 Grant or award +1,500 63,611 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-12-29 Sale −371 $17.81 $6,608 63,240 D
Open-market sales · 371 sh · avg $17.81 · $6,608
Loading xslF345X03/edgar.xml…